ZA9610297B - Bioartificial devices and cellular matrices therefor - Google Patents
Bioartificial devices and cellular matrices thereforInfo
- Publication number
- ZA9610297B ZA9610297B ZA9610297A ZA9610297A ZA9610297B ZA 9610297 B ZA9610297 B ZA 9610297B ZA 9610297 A ZA9610297 A ZA 9610297A ZA 9610297 A ZA9610297 A ZA 9610297A ZA 9610297 B ZA9610297 B ZA 9610297B
- Authority
- ZA
- South Africa
- Prior art keywords
- cellular matrices
- bioartificial devices
- matrices therefor
- therefor
- matrix
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/0231—Chemically defined matrices, e.g. alginate gels, for immobilising, holding or storing cells, tissue or organs for preservation purposes; Chemically altering or fixing cells, tissue or organs, e.g. by cross-linking, for preservation purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/022—Artificial gland structures using bioreactors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/222—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0012—Cell encapsulation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
- C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/70—Polysaccharides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Botany (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/568,694 US5830492A (en) | 1992-02-24 | 1995-12-07 | Bioartificial devices and cellular matrices therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA9610297B true ZA9610297B (en) | 1997-06-18 |
Family
ID=24272337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9610297A ZA9610297B (en) | 1995-12-07 | 1996-12-06 | Bioartificial devices and cellular matrices therefor |
Country Status (9)
Country | Link |
---|---|
US (1) | US5830492A (xx) |
EP (2) | EP0865288B1 (xx) |
JP (1) | JP3606585B2 (xx) |
AT (2) | ATE247478T1 (xx) |
AU (1) | AU714465B2 (xx) |
CA (1) | CA2239498C (xx) |
DE (2) | DE69635940T2 (xx) |
WO (1) | WO1997020569A2 (xx) |
ZA (1) | ZA9610297B (xx) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6231881B1 (en) | 1992-02-24 | 2001-05-15 | Anton-Lewis Usala | Medium and matrix for long-term proliferation of cells |
US6352707B1 (en) * | 1992-02-24 | 2002-03-05 | Anton-Lewis Usala | Transplant encapsulation in a hydrogel matrix to obscure immune recognition |
US5908633A (en) * | 1992-02-24 | 1999-06-01 | Usala; Anton-Lewis | Bioartificial hormone releasing device |
US6703017B1 (en) | 1994-04-28 | 2004-03-09 | Ixion Biotechnology, Inc. | Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures |
WO1999060105A1 (en) * | 1998-05-15 | 1999-11-25 | Modex Therapeutiques, S.A. | Flat sheet cell encapsulation device |
AU757968B2 (en) * | 1998-07-10 | 2003-03-13 | Encelle, Inc. | Methods for increasing vascularization and promoting wound healing |
FR2801313A1 (fr) | 1999-05-19 | 2001-05-25 | Coletica | Produit collagenique contenant du collagene d'origine marine a faible odeur et de preference a proprietes mecaniques ameliorees, ainsi que son utilisation sous forme de compositions ou de produits cosmetiques ou pharmaceutiques |
CA2385628A1 (en) * | 1999-09-27 | 2001-04-05 | Ammon B. Peck | Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures |
AU2001258091A1 (en) * | 2000-05-05 | 2001-11-20 | Mcgill University | A device for cell implantation |
US6790454B1 (en) | 2000-05-26 | 2004-09-14 | Coletica | Processes for the preparation of novel collagen-based supports for tissue engineering, and biomaterials obtained |
JP3747412B2 (ja) * | 2000-05-26 | 2006-02-22 | エンゲルハード・リヨン | 組織工学用にデザインされた担体を製造するための水生動物起源のコラーゲンの使用並びにそれにより得られる担体及び生体材料 |
FR2809412A1 (fr) * | 2000-05-26 | 2001-11-30 | Coletica | Utilisation de collagene d'origine aquatique pour la realisation de supports destines a l'ingenierie tissulaire, et supports et biomateriaux obtenus |
FR2809314B1 (fr) * | 2000-05-26 | 2005-11-18 | Coletica | Utilisation de collagene d'origine aquatique pour la realisation de supports destines a l'ingenierie tissulaire, et supports et biomateriaux obtenus |
US6974679B2 (en) | 2000-05-26 | 2005-12-13 | Coletica | Support with collagen base for tissue engineering and manufacture of biomaterials |
EP1289537B1 (en) | 2000-05-31 | 2005-11-30 | Encelle, Inc. | Method of treating chronic ulcers |
DE60239868D1 (de) | 2001-06-12 | 2011-06-09 | Univ Johns Hopkins Med | Reservoirvorrichtung für die intraokulare arzneimittelabgabe |
US7156877B2 (en) | 2001-06-29 | 2007-01-02 | The Regents Of The University Of California | Biodegradable/bioactive nucleus pulposus implant and method for treating degenerated intervertebral discs |
US20080086792A1 (en) | 2006-10-13 | 2008-04-17 | Thomas Charles Kuracina | Method and apparatus for diverting sweat, liquid, moisture or the like from an eye |
DE60323943D1 (de) * | 2002-02-21 | 2008-11-20 | Encelle Inc | Immobilisierte bioaktive hydrogel matrizen für oberflächenbeschichtungen |
EP1922052B1 (en) * | 2005-08-08 | 2010-11-03 | Angstrom Medica, Inc. | Cement products and methods of making and using the same |
US20070098695A1 (en) * | 2005-10-31 | 2007-05-03 | Deolden James | Methods of islet separation during isolation |
JP4853637B2 (ja) | 2006-08-08 | 2012-01-11 | Kisco株式会社 | 細胞培養用基材およびその製造方法 |
WO2009029734A2 (en) | 2007-08-28 | 2009-03-05 | Pioneer Surgical Technology, Inc. | Cement products and methods of making and using the same |
JP5237714B2 (ja) * | 2008-07-29 | 2013-07-17 | BioROIS株式会社 | 細胞輸送用担体及びそれを使用した細胞の輸送方法 |
US8623395B2 (en) | 2010-01-29 | 2014-01-07 | Forsight Vision4, Inc. | Implantable therapeutic device |
EP2391419B1 (en) | 2009-01-29 | 2019-06-12 | ForSight Vision4, Inc. | Posterior segment drug delivery |
US9033911B2 (en) | 2010-08-05 | 2015-05-19 | Forsight Vision4, Inc. | Injector apparatus and method for drug delivery |
WO2012019176A2 (en) | 2010-08-05 | 2012-02-09 | Forsight Vision4 Inc. | Implantable therapeutic device |
JP5592842B2 (ja) | 2011-06-24 | 2014-09-17 | Kisco株式会社 | 細胞培養用基膜、細胞培養用基材、及び細胞培養用基材の製造方法 |
CA2848385C (en) | 2011-09-16 | 2021-10-26 | Forsight Vision4, Inc. | Methods and apparatus to exchange a fluid of an implantable device |
WO2013045689A1 (en) | 2011-09-29 | 2013-04-04 | BIORIGEN Srl | Therapeutic use of gelatin hydrogels with a gel-sol transition at body temperature |
EP2574349A1 (en) * | 2011-09-29 | 2013-04-03 | Biorigen S.r.l | Therapeutic use of gelatin hydrogels with a gel-sol transition at body temperature |
CA2854160A1 (en) | 2011-11-02 | 2013-05-10 | Halscion, Inc. | Methods and compositions for wound treatment |
ES2559467T3 (es) | 2011-12-23 | 2016-02-12 | Pioneer Surgical Technology, Inc. | Matriz continua con partículas osteoconductoras dispersadas en la misma, procedimiento de formación, y su uso para regenerar el hueso con la misma |
JP6385423B2 (ja) | 2013-03-28 | 2018-09-05 | フォーサイト・ビジョン フォー・インコーポレーテッド | 治療物質送達用の眼移植片 |
EP3377009B1 (en) | 2015-11-20 | 2020-10-28 | ForSight Vision4, Inc. | Porous structures for extended release drug delivery devices |
US11980700B2 (en) | 2017-03-08 | 2024-05-14 | Alafair Biosciences, Inc. | Hydrogel medium for the storage and preservation of tissue |
US20220409773A1 (en) * | 2019-06-28 | 2022-12-29 | Mochida Pharmaceutical Co., Ltd. | Transplantation device using chemically crosslinked alginic acid |
WO2022137345A1 (ja) * | 2020-12-22 | 2022-06-30 | 持田製薬株式会社 | 化学架橋アルギン酸を用いた移植用デバイス |
JP7451818B1 (ja) | 2023-11-10 | 2024-03-18 | 洋之 高尾 | Diffusion Chamber型人工膵島器 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0142344A3 (en) * | 1983-11-10 | 1986-10-08 | The Wistar Institute Of Anatomy And Biology | Medium for cloning and long-term serial cultivation of human endothelial cells |
US5132223A (en) * | 1983-11-10 | 1992-07-21 | Thomas Jefferson University | Process and medium for cloning and long-term serial cultivation of adult human endothelial cells |
US4868121A (en) * | 1985-02-07 | 1989-09-19 | Mcdonnell Douglas Corporation | Islet isolation process |
US4769404A (en) * | 1985-02-28 | 1988-09-06 | Technicon Instruments Corporation | Lyophilization of reagent-coated particles |
GB8604497D0 (en) * | 1986-02-24 | 1986-04-03 | Connaught Lab | Separation of islets of langerhans |
US5079160A (en) * | 1987-06-08 | 1992-01-07 | Lacy Paul E | Method to isolate clusters of cell subtypes from organs |
US5071741A (en) * | 1988-04-18 | 1991-12-10 | Cryolife, Inc. | Cryoprotective agent and its use in cryopreservation of cellular matter |
SU1724687A1 (ru) * | 1990-05-05 | 1992-04-07 | Институт полиомиелита и вирусных энцефалитов АМН СССР | Способ получени желатиновых микроносителей дл культивировани клеток животных |
US5145770A (en) * | 1990-06-04 | 1992-09-08 | Biosurface Technology, Inc. | Cryopreservation of cultured epithelial sheets |
EP0585368B1 (en) * | 1991-04-25 | 1997-08-06 | Brown University Research Foundation | Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products |
JP3291297B2 (ja) * | 1992-02-24 | 2002-06-10 | エンセル,インコーポレイテッド | 生物人工内分泌装置 |
US5422261A (en) * | 1993-04-16 | 1995-06-06 | Baxter International Inc. | Composition containing collagenase and chymopapain for hydrolyzing connective tissue to isolate cells |
ATE275194T1 (de) * | 1994-01-13 | 2004-09-15 | Rogosin Inst | Makroeingekapselte sekretorische zellen |
-
1995
- 1995-12-07 US US08/568,694 patent/US5830492A/en not_active Expired - Lifetime
-
1996
- 1996-11-14 EP EP96941993A patent/EP0865288B1/en not_active Expired - Lifetime
- 1996-11-14 CA CA002239498A patent/CA2239498C/en not_active Expired - Lifetime
- 1996-11-14 EP EP03075752A patent/EP1321516B1/en not_active Expired - Lifetime
- 1996-11-14 WO PCT/US1996/018209 patent/WO1997020569A2/en active IP Right Grant
- 1996-11-14 AU AU11192/97A patent/AU714465B2/en not_active Expired
- 1996-11-14 DE DE69635940T patent/DE69635940T2/de not_active Expired - Lifetime
- 1996-11-14 JP JP52127597A patent/JP3606585B2/ja not_active Expired - Lifetime
- 1996-11-14 AT AT96941993T patent/ATE247478T1/de not_active IP Right Cessation
- 1996-11-14 AT AT03075752T patent/ATE321126T1/de not_active IP Right Cessation
- 1996-11-14 DE DE69629583T patent/DE69629583T2/de not_active Expired - Lifetime
- 1996-12-06 ZA ZA9610297A patent/ZA9610297B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DE69629583D1 (de) | 2003-09-25 |
EP1321516A3 (en) | 2003-07-02 |
WO1997020569A3 (en) | 1997-09-18 |
ATE247478T1 (de) | 2003-09-15 |
DE69635940T2 (de) | 2006-10-26 |
CA2239498C (en) | 2003-09-09 |
AU1119297A (en) | 1997-06-27 |
JP3606585B2 (ja) | 2005-01-05 |
EP1321516A2 (en) | 2003-06-25 |
EP1321516B1 (en) | 2006-03-22 |
JP2000507202A (ja) | 2000-06-13 |
US5830492A (en) | 1998-11-03 |
AU714465B2 (en) | 2000-01-06 |
DE69635940D1 (de) | 2006-05-11 |
EP0865288B1 (en) | 2003-08-20 |
WO1997020569A2 (en) | 1997-06-12 |
CA2239498A1 (en) | 1997-06-12 |
ATE321126T1 (de) | 2006-04-15 |
EP0865288A2 (en) | 1998-09-23 |
DE69629583T2 (de) | 2004-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA9610297B (en) | Bioartificial devices and cellular matrices therefor | |
DE69427908T2 (de) | Eine gelpräparation aus vernetzter gelatine, die einen basischen wachstumsfaktor für fibroblasten enthält | |
ES2172573T3 (es) | Hidrogel basado en albumina. | |
NO954188L (no) | Modifisert-protein- og -peptid - farmasöytika | |
ATE449619T1 (de) | Methode zur verminderung der immunerkennung | |
MX9306029A (es) | Composiciones protectoras y regenerativas de tejidos. | |
ATE333849T1 (de) | In-vitro herstellung von transplantierbarem knorpelgewebe | |
CA2203936A1 (en) | Boronic ester and acid compounds, synthesis and uses | |
TR199701212T1 (xx) | �drar� tutamama halinin tedavisi i�in alfa IL- agonistlerinin kullan�lmas�. | |
ATE161174T1 (de) | Feste zubereitung mit hoher freisetzung, ihre herstellung und verwendung | |
MX9705954A (es) | Formulaciones y metodos para reducir irritacion de la piel. | |
AU635074B2 (en) | S(+)-ibuprofen-l-amino acid and s(+)-ibuprofen-d-amino acid as onset hastened enhanced analgesics | |
ATE193653T1 (de) | Herstellungsverfahren für cetrorelix lyophilisat | |
KR970702733A (ko) | 활성물질의 방출 조절용 콜라겐 제제(collagen preparation the controlled release of active substances) | |
ES2133633T3 (es) | Procedimiento para la produccion de polvos, granulados o peletes que contienen una sustancia activa, con una estructura a base de macromoleculas hidrofilas, y su utilizacion. | |
ES2057544T3 (es) | Composiciones estabilizadas a base de fgf. | |
CA2410968A1 (en) | Method of treating chronic ulcers | |
CA2324467A1 (en) | Formulations for protection of peg-interferon alpha conjugates | |
CA2158609A1 (en) | 5 .alpha.-reductase inhibitors | |
CA2025070A1 (en) | Recombinant aprotinin variants genetically engineered process for the microbial preparation of homgeneously processed aprotinin variants and the therapeutic use thereof | |
DE59401990D1 (de) | Imidazolyl-substituierte Phenylessigsäureprolinamide | |
CA2337051A1 (en) | Methods for increasing vascularization and promoting wound healing | |
IT1226796B (it) | Composizione farmaceutica utile per il trattamento di malattie cardiovascolari. | |
DE59410140D1 (de) | Rinderovarzellinie (FROv) zur Virusvermehrung |